About Us
DotBio’s proprietary DotBody technology platform is based on the concept of modular design. The DotBodies are human, stabilized VH domains generated from a non-immunogenic, clinically-validated human VH germline. By prefabricating antibody modules with specific functions, DotBio is able to combine them on demand to build multi-functional antibodies. This high throughput process allows DotBio to generate bi- and tri-specific antibodies, antibody-drug conjugates (ADCs) and intracellular antibodies in a matter of months.
